Trilogy falls out of favour with investors
Trilogy's share price has plunged 56% since an August high.
Trilogy International’s share price has more than halved from its all-time high in August last year, and remained stagnant after it released full-year results last Friday.
The natural skincare and candle company’s share price was on a roll this time last year, reaching a peak of $4.90 in August.
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Wed, 31 May 2017
Wed, 31 May 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Trilogy falls out of favour with investors
67390